Introduction
shown variable sensitivity and specificity towards VAP detection (12, 14) . This raises potential 81 issues of misdiagnosis and emphasizes the need for further research on specific VAP biomarkers.
82
BAL has been a widely accepted matrix to study pulmonary infections (15, 16 (ThermoFisher, Scientific, San Jose, CA). The flow-through protein solution was subjected to a 136 modified filter-aided sample preparation (21). Briefly, the samples were buffer exchanged to 50 137 mM ammonium bicarbonate buffer, pH 7.8, and the proteins were denatured using 8 M urea (1 138 hour), reduced using 1 mM dithiothreitol (1 hour, 37 °C), and alkylated with 40 mM iodoacetamide
139
(1 hour, 37 °C). The proteins were digested with Trypsin Gold overnight at 37°C (Promega, 140 Madison, WI). The resulting peptides were de-salted using C18 SPE cartridges (Waters, Milford, 141 MA) and eluted with 70% acetonitrile (ACN) with 0.1% trifluoroacetic acid (v/v) (Waters). The 142 eluted peptides were vacuum-dried and frozen at -20 °C until LC-MS/MS analysis. On the day of 143 analysis, the samples were reconstituted in 0.1% formic acid. Sample preparation and data 144 acquisition were randomized separately in order to minimize bias.
145
LC-MS/MS analysis was performed using a nanoAcquity ultra performance liquid 146 chromatography system (Waters, Milford, MA) coupled to an Orbitrap Fusion Lumos Tribrid mass 147 spectrometer (Thermo Fisher, San Jose, CA). One μg of peptides from each sample was separated 148 on a BEH C18, 1.7 μM, 0.1 x 100 mm column (Waters, Milford, MA) using a 83.5 minute gradient 149 from 3 to 90% solvent B (ACN, 0.1% FA) and 97 to 10% solvent A (Water, 0.1% FA) at a flow 150 rate of 0.5 μL/min. The following gradient conditions were employed: 3 to 7% B for 1 minute, 7 151 to 25% B for 1 to 72 minutes, 25 to 45% B for 10 minutes, 45 to 90% B for 0.5 minutes, 90% B 152 for 0.5 minute and column equilibration at 3% B for 10 minutes. MS spectra were acquired over a 153 scan range of m/z 380 to 2000 using the orbitrap at 120,000 resolution followed by quadrupole 154 isolation (width 1.6 TH) of precursor ions for data-dependent higher-energy collisional were set to 10 ppm and 0.5 Da, respectively. The target false discovery rate (FDR) was set to 1%.
165
Peptide quantitation was performed using label-free quantitation based on precursor ion area under 166 the curve (AUC).
167
For microbial proteomics, we curated a list of common VAP pathogens comprised of gram-168 positive, gram-negative bacteria and yeast (Supplemental Table S1 ) from literature. Proteome
169
FASTA files of the listed pathogens were used as microbiome database and proteomics raw data 170 generated in this study were searched with Mascot with above mentioned parameters. Figure 1A . Duration of intubation was longer in VAP (≥ 7 days) than 226 control patients (≤ 5 days). A total of 8 patients including 3 control patients and 5 VAP patients 227 were given broad spectrum antibiotics at intubation, whereas no antibiotics were given to the 228 remaining 2 controls and 6 VAP patients. In VAP patients, antibiotic prophylaxis at the time of 229 intubation did not show any better protection compared to no antibiotics; also, there was no clear- (MRSA) ( Figure 1B ). As all patients in our study cohort were administered a standard-of-care 235 regimen of antibiotics, their impact on the patient proteome and metabolome was not evaluated.
236

ETA proteome reveals neutrophil mediated response in VAP
237
We identified a total of 3067 unique proteins in ETA collections across all patients and time points.
238
We compared patient-matched ETA and BAL collected on the same day and identified 1811 and Table S2 ).
245
These suggest enrichment of proteins associated to host immunity in both ETA and BAL. Further,
246
Bland-Altman comparison of these shared proteins showed that there was no significant bias 247 between ETA and BAL as most of the data sits between the 95% confidence interval upper limit 248 of 4.1 and the lower limit of -4.4. Figure 2B ). The GO terms for the biological processes related 249 to innate and humoral immunity were similarly enriched across both fluids ( Figure 2C ). This 250 suggests similarities in proteome composition between BAL and ETA.
251
Due to the relative ease-of-access and increased sampling availability, we focused our study on 252 ETA. Since intubation was variable across VAP patients and controls, we compared the first day 253 of intubation (Baseline) against subsequent time points in VAP patients, and also compared 254 Baseline ETA proteome in VAP and control patients.
255
The patients enrolled in our study were intubated for variable length of time and developed 
263
In VAP patients, a total of 1823 and 1603 proteins were identified in the Baseline and VAP positive 264 ETA, respectively, with 1269 proteins shared between time points ( Figure 3B) Table S5 ). Absence of these proteins in VAP positive may 294 imply pathogen binding and clearance. Both isoform 2 of nucleoside diphosphate kinase A (NME-295 1) and CRP were detected in VAP ETA only (Table 3) . To gain further insight, the significant 296 differentially abundant proteins were mapped to Reactome pathways (Table 4) 
310
To identify early VAP response mechanisms, we evaluated ETA collected two days prior to 311 clinical diagnosis (pre-VAP). We identified 21 significantly differentially abundant proteins (p < 312 0.05) with a fold change >2 compared to Baseline ( Figure 3C , Table 5 ). Consistent with our prior 
325
VAP patients harbor metabolic signatures of oxidative stress
326
Similar to the proteomic analysis, Bland-Altman analysis showed no significant bias of metabolites 327 in ETA and BAL matrices as the majority of data were within the limits of agreement for 95% 328 confidence interval (mean difference of 0, upper limit of 4.7 and lower limit of -4.8) ( Figure 5A ).
329
The unsupervised temporal clustering using median metabolite concentrations showed two distinct Table 6 ). Of these, high concentrations of amino acids and C4-OH were detected in a majority of time points, whereas peptides attributed to gram-positive were only 363 detected at day 1 post intubation in two patients ( Figure 6B ). Based on peptide specificity, gram-364 negative pathogens were detected in 9 out of 10 VAP patients at all-time points. Gram-positives 365 were only detected in 4 out of 10 patients, with highest peptide counts in patient 16. This suggests 366 that VAP infection is majorly dominated by gram-negative bacterial species. Furthermore, species-367 specific peptides were detectable days before culture based diagnosis.
368
Discussion
369
The present study describes VAP mediated host responses in ETA and BAL of 16 intubated 370 patients. This is also the first detailed characterization of the ETA proteome and metabolome. We 371 detected 3067 unique proteins in ETA sampled longitudinally, compared to 1139 proteins in BAL.
372
We also observed >10% increase in unique BAL proteins compared to previous studies (16, 32) .
373
Despite our observation of a 3-fold higher proteome diversity and although less invasive, ETA has 374 been historically overlooked in favor of BAL (33). Our study revealed that ETA is functionally 375 diverse and highly enriched in proteins involved in innate and adaptive immunity, suggesting that 376 it is an attractive source to study lung infection. In VAP patients, we observed up-regulation of 377 inflammation and neutrophil-mediated innate immunity in the respiratory tract during VAP 378 infection, leading to pathogen processing (Figure 7 ). Elevated levels of vinculin and myosins may 379 imply extracellular matrix (ECM) adhesion and migration of neutrophils ( Figure 7B) (34, 35) .
380
Increased abundance of pathogen recognition molecules ficolin-1 and properdin in ETA may be 381 linked to complement system activation via interaction with bacterial polysaccharides (36). In 382 support of this, antimicrobial neutrophil proteins S100A8 and S100A9, with proinflammatory and 383 chemotactic activity (37), were highly elevated during VAP infection. Furthermore, the VAP- Ultimately, these alterations to the host environment may be reflected at the pulmonary interface.
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Our study has focused on ETA to conduct a molecular survey of upper airways during VAP LGALS3BP;CFL1;CFD;AHSG;CLEC3B 2.55E-03 
